These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34269304)

  • 1. Efficacy comparison between microwave ablation combined with radiation therapy and radiation therapy alone for locally advanced nonsmall-cell lung cancer.
    Song P; Sun W; Pang M; He W; Zhang W; Sheng L
    J Cancer Res Ther; 2021 Jul; 17(3):715-719. PubMed ID: 34269304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
    Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
    J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
    Mantel F; Müller E; Kleine P; Zimmermann M; Exner F; Richter A; Weick S; Ströhle S; Polat B; Höcht S; Flentje M
    Strahlenther Onkol; 2021 May; 197(5):405-415. PubMed ID: 33725133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the incidence of ≥ grade 2 radiation pneumonitis between intensity-modulated radiotherapy and three-dimensional conformal radiotherapy in patients with unresectable non-small cell lung cancer treated with durvalumab after concurrent chemoradiotherapy.
    Masuo M; Shinohara E; Kitano M; Maruta R; Chonabayashi S; Endo S; Matumoto S; Nishiyama N; Machitori Y; Kobayashi M
    Jpn J Clin Oncol; 2024 Mar; 54(3):312-318. PubMed ID: 38010609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Yom SS; Liao Z; Liu HH; Tucker SL; Hu CS; Wei X; Wang X; Wang S; Mohan R; Cox JD; Komaki R
    Int J Radiat Oncol Biol Phys; 2007 May; 68(1):94-102. PubMed ID: 17321067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An esophagus-sparing technique to limit radiation esophagitis in locally advanced non-small cell lung cancer treated by simultaneous integrated boost intensity-modulated radiotherapy and concurrent chemotherapy.
    Ma L; Qiu B; Li Q; Chen L; Wang B; Hu Y; Liu M; Zhang L; Huang Y; Deng X; Xia Y; Lin M; Liu H
    Radiat Oncol; 2018 Jul; 13(1):130. PubMed ID: 30016978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer.
    Chi A; Wen S; Monga M; Almubarak M; He X; Rojanasakul Y; Tse W; Remick SC
    PLoS One; 2016; 11(9):e0162453. PubMed ID: 27611833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome and toxicity of intensity modulated radiotherapy with simultaneous integrated boost in locally advanced non-small cell lung cancer patients.
    Fondevilla Soler A; López-Guerra JL; Dzugashvili M; Sempere Rincón P; Sautbaet A; Castañeda P; Díaz JM; Praena-Fernandez JM; Rivin Del Campo E; Azinovic I
    Clin Transl Oncol; 2017 Dec; 19(12):1469-1477. PubMed ID: 28589434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of efficacy and safety between simultaneous integrated boost intensity-modulated radiotherapy and standard-dose intensity-modulated radiotherapy in locally advanced esophageal squamous cell carcinoma: a retrospective study.
    Lan W; Lihong L; Chun H; Shutang L; Qi W; Liang X; Xiaoning L; Likun L
    Strahlenther Onkol; 2022 Sep; 198(9):802-811. PubMed ID: 35029718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of intensity modulated radiotherapy with involved field radiotherapy for Japanese patients with locally advanced non-small cell lung cancer.
    Abe T; Iino M; Saito S; Aoshika T; Ryuno Y; Ohta T; Igari M; Hirai R; Kumazaki Y; Miura Y; Kaira K; Kagamu H; Noda SE; Kato S
    J Radiat Res; 2021 Sep; 62(5):894-900. PubMed ID: 34260719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New dose constraint reduces radiation-induced fatal pneumonitis in locally advanced non-small cell lung cancer patients treated with intensity-modulated radiotherapy.
    Khalil AA; Hoffmann L; Moeller DS; Farr KP; Knap MM
    Acta Oncol; 2015; 54(9):1343-9. PubMed ID: 26198657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute hospitalizations after proton therapy versus intensity-modulated radiotherapy for locally advanced non-small cell lung cancer in the durvalumab era.
    Iocolano M; Yegya-Raman N; Friedes C; Wang X; Kegelman T; Lee SH; Duan L; Li B; Levin WP; Cengel KA; Konski A; Langer CJ; Cohen RB; Sun L; Aggarwal C; Doucette A; Xiao Y; Kevin Teo BK; O'Reilly S; Zou W; Bradley JD; Simone CB; Feigenberg SJ
    Cancer; 2024 Jun; 130(11):2031-2041. PubMed ID: 38294959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensity-Modulated Radiation Therapy May Improve Local-Regional Tumor Control for Locally Advanced Non-Small Cell Lung Cancer Compared With Three-Dimensional Conformal Radiation Therapy.
    Wang J; Zhou Z; Liang J; Feng Q; Xiao Z; Hui Z; Wang X; Lv J; Chen D; Zhang H; Ji Z; Cao J; Liu L; Jiang W; Men Y; Xu C; Dai J; Yin W; Wang L
    Oncologist; 2016 Dec; 21(12):1530-1537. PubMed ID: 27628491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe late esophagus toxicity in NSCLC patients treated with IMRT and concurrent chemotherapy.
    Chen C; Uyterlinde W; Sonke JJ; de Bois J; van den Heuvel M; Belderbos J
    Radiother Oncol; 2013 Aug; 108(2):337-41. PubMed ID: 24074814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study.
    Jeter MD; Gomez D; Nguyen QN; Komaki R; Zhang X; Zhu X; O'Reilly M; Fossella FV; Xu T; Wei X; Wang H; Yang W; Tsao A; Mohan R; Liao Z
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):730-737. PubMed ID: 29248169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.
    Shi A; Zhu G; Wu H; Yu R; Li F; Xu B
    Radiat Oncol; 2010 May; 5():35. PubMed ID: 20462424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non-small-cell Lung Cancer.
    Ling DC; Hess CB; Chen AM; Daly ME
    Clin Lung Cancer; 2016 Jan; 17(1):18-23. PubMed ID: 26303127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between radiation pneumonitis and tumor response in patients with NSCLC treated with chemoradiation.
    MacManus MP; Ball D; Hicks RJ
    Radiat Oncol; 2014 Oct; 9():217. PubMed ID: 25318863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy.
    Koshy M; Malik R; Spiotto M; Mahmood U; Rusthoven CG; Sher DJ
    Lung Cancer; 2017 Jun; 108():222-227. PubMed ID: 28625640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk and predictors for early radiation pneumonitis in patients with stage III non-small cell lung cancer treated with concurrent or sequential chemoradiotherapy.
    Dang J; Li G; Zang S; Zhang S; Yao L
    Radiat Oncol; 2014 Jul; 9():172. PubMed ID: 25074618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.